BSE’s Surveillance department (Notice No. 20260413-31, dated 13 April 2026) issued this notice to inform members and investors that it had sought clarifications from two listed companies regarding news articles appearing in newspapers, websites, and television channels. Both companies have submitted their replies, which are attached to the notice.

Key Points

• BSE Surveillance sought clarifications from two companies to verify accuracy of media reports.
• India Tourism Development Corporation Ltd (Scrip Code: 532189) provided a reply in response to a news item on NDTV Profit.
• AAVAS Financiers Ltd (Scrip Code: 541988) provided a reply in response to a news item on ET CFO (Economic Times).
• Replies from both companies are attached to the notice for transparency to members and investors.

Regulatory Changes

No regulatory changes have been introduced. This is a routine surveillance and disclosure exercise.

Compliance Requirements

No new compliance requirements are imposed on members or investors. The notice is informational. The two companies have already fulfilled their obligation by submitting clarifications to BSE.

Important Dates

• Notice Date: 13 April 2026

Impact Assessment

Low market impact. This is a standard surveillance measure by BSE to ensure transparency and accuracy of information available to market participants. The attached company replies may have stock-specific implications depending on the content of the clarifications, but the notice itself does not introduce any trading restrictions, listing changes, or compliance mandates.

BSE’s Surveillance department (DOSS) has sought clarifications from two listed companies — Sun Pharmaceutical Industries Ltd and India Tourism Development Corporation Ltd — regarding news articles circulating in newspapers, websites, and television channels. This is a routine exercise to verify accuracy of news and keep members and investors informed.

Key Points

• BSE Notice No. 20260410-42 dated 10 April 2026 pertains to clarification requests on news articles.
• Sun Pharmaceutical Industries Ltd (Scrip Code: 524715) has submitted its reply in response to a news article from moneycontrol.com; the reply is attached to the notice.
• India Tourism Development Corporation Ltd (Scrip Code: 532189) has been asked to clarify a news article from ndtvprofit.com; reply is still awaited.
• Notice issued by Sanjay Jain (Deputy Vice President, Surveillance) and Shreya Ghose (Manager, Surveillance).

Regulatory Changes

No regulatory changes are introduced by this circular.

Compliance Requirements

• India Tourism Development Corporation Ltd (Scrip Code: 532189) is required to submit its clarification to BSE regarding the news article published on ndtvprofit.com.
• No compliance action is required from other market participants.

Important Dates

• Notice Date: 10 April 2026
• Sun Pharma reply: Received and attached as of notice date.
• ITDC reply: Awaited as of notice date.

Impact Assessment

This is a routine surveillance disclosure with minimal market impact. Sun Pharma’s clarification may provide informational value to investors monitoring the stock. ITDC’s pending response could attract attention until the clarification is submitted. No trading restrictions or penalties are imposed.